Immunoreactive Characteristics and Classification of Hyperparathyroidism
- PMID: 12114650
- DOI: 10.1007/BF02739877
Immunoreactive Characteristics and Classification of Hyperparathyroidism
Abstract
Hyperparathyroidism is caused mainly by three different conditions: namely, secondary hyperplasia, primary hyperplasia, and adenoma with only a few cases due to carcinomas. Histological distinction among these diseases is still difficult. In an attempt to characterize the three conditions, 17 cases from patients with hyperparathyroidism and 12 with normal glands were investigated immunohistochemically using antibodies against PTH, PTHrP, Ki-67 (MIB-1), and chromogranin A. The normal glands showed a diffuse staining pattern for PTH, and focal staining for PTHrP and for chromogranin A. Secondary hyperplasia demonstrated either focal, diffuse, or mixed staining in one gland with the three antibodies. For the primary hyperplasias and adenomas, the cases could be divided into two groups. The first group (group I), including 1 case of primary hyperplasia and 3 cases of adenoma, showed a homogeneous staining pattern with all three antibodies. A heterogeneous staining pattern similar to secondary hyperplasia was found in the other 8 cases that formed the second group (group II). There were five types of cytologic staining patterns after immunostaining. In secondary hyperplasia and group II, several patterns appeared simultaneously. On the contrary, only one pattern was found in group I. The proliferative index (P1) from Ki-67 staining of group I was also significantly higher than in group II. A lower P1 was observed in the normal glands. The present results indicate that different immunohistochemical characteristics exist in primary hyperplasias and in adenomas.
Similar articles
-
Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study.Virchows Arch A Pathol Anat Histopathol. 1991;418(4):295-9. doi: 10.1007/BF01600157. Virchows Arch A Pathol Anat Histopathol. 1991. PMID: 2024450
-
Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.J Clin Endocrinol Metab. 1996 Apr;81(4):1598-606. doi: 10.1210/jcem.81.4.8636374. J Clin Endocrinol Metab. 1996. PMID: 8636374
-
A comparative study of p53 immunoexpression in parathyroid hyperplasias secondary to uremia, primary hyperplasias, adenomas and carcinomas.Eur J Endocrinol. 1998 Jul;139(1):78-83. doi: 10.1530/eje.0.1390078. Eur J Endocrinol. 1998. PMID: 9703382
-
Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.J Clin Endocrinol Metab. 1997 Aug;82(8):2681-8. doi: 10.1210/jcem.82.8.4117. J Clin Endocrinol Metab. 1997. PMID: 9253354
-
[Primary hyperparathyroidism. An analysis of 152 patients with special references to acute life threatening complications (acute hyperparathyroidism)].Schweiz Med Wochenschr. 1976;106 Suppl 3:1-61. Schweiz Med Wochenschr. 1976. PMID: 795028 Review. German.
Cited by
-
Comparative analysis of clonality and pathology in primary and secondary hyperparathyroidism.Virchows Arch. 1997 Mar;430(3):247-51. doi: 10.1007/BF01324809. Virchows Arch. 1997. PMID: 9099983
-
Parathyroid invasion, nodal recurrence, and lung metastasis by papillary carcinoma of the thyroid.J Clin Pathol. 2004 Mar;57(3):245-9. doi: 10.1136/jcp.2003.012070. J Clin Pathol. 2004. PMID: 14990593 Free PMC article.
-
Clonality of the parathyroid nodules with uremic parathyroid hyperplasia.Pathol Oncol Res. 1997 Sep;3(3):198-203. doi: 10.1007/BF02899921. Pathol Oncol Res. 1997. PMID: 18470730
References
LinkOut - more resources
Research Materials